Title:
自己免疫疾患の診断、予防、および／または治療
Document Type and Number:
Japanese Patent JP7411718
Kind Code:
B2
Abstract:
Compositions, methods, and kits are for the diagnosis, prevention and/or treatment of autoimmune diseases by detecting, targeting, and/or eliminating epitope-specific autoimmune cells. The compositions include a conjugate of an epitope and an agent that allows for detecting, targeting, and/or eliminating epitope-specific autoimmune cells.
Inventors:
Chu, Chen Shen
Application Number:
JP2022076451A
Publication Date:
January 11, 2024
Filing Date:
May 06, 2022
Export Citation:
Assignee:
Immunowork, Limited Liability Company
International Classes:
A61K47/64; A61K31/137; A61K31/18; A61K31/365; A61K31/404; A61K31/407; A61K31/4184; A61K31/436; A61K31/44; A61K31/4418; A61K31/496; A61K31/506; A61K31/513; A61K31/517; A61K31/519; A61K31/675; A61K31/704; A61K31/706; A61K31/7068; A61K31/7105; A61K31/713; A61K33/243; A61K38/05; A61K38/13; A61K45/00; A61K48/00; A61P13/12; A61P17/00; A61P37/02; C07K14/705; C12N15/113; C12N15/12
Domestic Patent References:
| JP2011528789A |
Other References:
Br J Dermatol.,2000年,142(2),pp.321-330
KAO Liyo et al.,Identification of the Immunodominant Epitope Rewgion in Phospholipase A2 Receptor-Mediating Autoantibody Binding in Idiopathic Membranous Nephropathy,Journal of the American Society of Nephrology,2015年,Vol.26,pp.291-301
RESQUET Maryline et al.,Identification of a Major Epitope Recognized by PLA2R Autoantibodies in Primary Membranous Nephropathy,Journal of the American Society of Nephrology,2015年,Vol.26,pp.302-313
KAO Liyo et al.,Identification of the Immunodominant Epitope Rewgion in Phospholipase A2 Receptor-Mediating Autoantibody Binding in Idiopathic Membranous Nephropathy,Journal of the American Society of Nephrology,2015年,Vol.26,pp.291-301
RESQUET Maryline et al.,Identification of a Major Epitope Recognized by PLA2R Autoantibodies in Primary Membranous Nephropathy,Journal of the American Society of Nephrology,2015年,Vol.26,pp.302-313
Attorney, Agent or Firm:
Patent Attorney Corporation Shuwa Patent Office